{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:38:48Z","timestamp":1792597128748,"version":"4.5.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3,3]]},"DOI":"10.1093\/jnci\/djp534","type":"journal-article","created":{"date-parts":[[2010,2,6]],"date-time":"2010-02-06T02:10:22Z","timestamp":1265422222000},"page":"325-339","source":"Crossref","is-referenced-by-count":444,"title":["Impact of Human Papillomavirus (HPV)-6\/11\/16\/18 Vaccine on All HPV-Associated Genital Diseases in Young Women"],"prefix":"10.1093","volume":"102","author":[{"given":"Nubia","family":"Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne K.","family":"Kjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristj\u00e1n","family":"Sigurdsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole-Erik","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Hernandez-Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosette M.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darron R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Koutsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng Hseon","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patric\u00eda J.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Ault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Garland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepp","family":"Leodolter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven-Eric","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace W. K.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daron G.","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorma","family":"Paavonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Steben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Xavier","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Dillner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warner K.","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar A.","family":"Joura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Kurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slawomir","family":"Majewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan R.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa L.","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Taddeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amha","family":"Tadesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine T.","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa C.","family":"Lupinacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E. D.","family":"Giacoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Sings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret K.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa M.","family":"Hesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliav","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Haupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,3,3]]},"reference":[{"key":"key\n\t\t\t\t20170520221005_bib1","author":"Castellsague","journal-title":"HPV and Cervical Cancer in the World. 2007 Report"},{"key":"key\n\t\t\t\t20170520221005_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"issue":"6","key":"key\n\t\t\t\t20170520221005_bib3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N Engl J Med"},{"issue":"9518","key":"key\n\t\t\t\t20170520221005_bib4","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomized control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170520221005_bib5","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.ygyno.2008.06.029","article-title":"Impact of vaccination with Cervarix\u2122on subsequent HPV-16\/18 infection and cervical disease in women 15\u201325 years of age","volume":"110","author":"Harper","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"9580","key":"key\n\t\t\t\t20170520221005_bib6","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"issue":"19","key":"key\n\t\t\t\t20170520221005_bib7","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"issue":"19","key":"key\n\t\t\t\t20170520221005_bib8","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","author":"The FUTURE II Study Group","year":"2007","journal-title":"N Engl J Med"},{"issue":"9576","key":"key\n\t\t\t\t20170520221005_bib9","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60852-6","article-title":"Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3 and adenocarcinoma in situ: a combined analysis of four randomised clinical trials","volume":"369","author":"The FUTURE II Study Group","year":"2007","journal-title":"Lancet"},{"issue":"9574","key":"key\n\t\t\t\t20170520221005_bib10","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","article-title":"Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16 and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three clinical trials","volume":"369","author":"Joura","year":"2007","journal-title":"Lancet"},{"issue":"14","key":"key\n\t\t\t\t20170520221005_bib11","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"key\n\t\t\t\t20170520221005_bib12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.bjc.6604162","article-title":"Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening","volume":"98","author":"Coupe","year":"2008","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20170520221005_bib13","volume-title":"IARC Monographs on the Evaluation of Carcinogenic Risks to Humans"},{"issue":"3","key":"key\n\t\t\t\t20170520221005_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.inf.0000253970.29190.5a","article-title":"Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial","volume":"26","author":"Reisinger","year":"2007","journal-title":"Ped Infect Dis J"},{"issue":"5","key":"key\n\t\t\t\t20170520221005_bib15","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1542\/peds.2006-0461","article-title":"Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women","volume":"118","author":"Block","year":"2006","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170520221005_bib16","article-title":"Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine [published online ahead of print November 30, 2009]","author":"Block","journal-title":"Ped Infect Dis J"},{"issue":"10","key":"key\n\t\t\t\t20170520221005_bib17","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1086\/522864","article-title":"Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virologic evidence of HPV infection","volume":"196","author":"The FUTURE II Study Group","year":"2007","journal-title":"J Infect Dis"},{"issue":"7","key":"key\n\t\t\t\t20170520221005_bib18","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1086\/597309","article-title":"The impact of quadrivalent HPV (type 6\/11\/16\/18) L1 VLP vaccine on infection and disease due to oncogenic non-vaccine HPV types in sexually active women aged 16\u201326","volume":"199","author":"Wheeler","year":"2009","journal-title":"J Infect Dis."},{"issue":"7","key":"key\n\t\t\t\t20170520221005_bib19","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","article-title":"The impact of quadrivalent HPV (type 6\/11\/16\/18) L1 VLP vaccine on infection and disease due to oncogenic non-vaccine HPV types in generally HPV naive women aged 16\u201326","volume":"199","author":"Brown","year":"2009","journal-title":"J Infect Dis."},{"issue":"5","key":"key\n\t\t\t\t20170520221005_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"issue":"3","key":"key\n\t\t\t\t20170520221005_bib21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0272-2712(03)00053-2","article-title":"The Bethesda System 2001: an update of new terminology for gynecologic cytology","volume":"23","author":"Henry","year":"2003","journal-title":"Clin Lab Med"},{"issue":"11","key":"key\n\t\t\t\t20170520221005_bib22","first-page":"807","article-title":"Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee","volume":"50","author":"Sideri","year":"2005","journal-title":"J Reprod Med"},{"issue":"1","key":"key\n\t\t\t\t20170520221005_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1128\/CDLI.10.1.108-115.2003","article-title":"Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16 and 18 by a multiplexed luminex assay","volume":"10","author":"Opalka","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"27","key":"key\n\t\t\t\t20170520221005_bib24","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1016\/S0264-410X(01)00093-7","article-title":"Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus virus-like particles","volume":"19","author":"Palker","year":"2001","journal-title":"Vaccine"},{"issue":"8","key":"key\n\t\t\t\t20170520221005_bib25","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1128\/CDLI.12.8.959-969.2005","article-title":"Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomavirus 6, 11, 16 and 18","volume":"12","author":"Dias","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"key\n\t\t\t\t20170520221005_bib26","article-title":"International patent numbers WO 2003\/019143 A2 (Merck, Jansen, Taddeo, Li, Dicello, Fluorescent Multiplex HPV PCR Assays Using Multiple Fluorophores. March 6, 2003), WO 2006\/116276 A2 (Merck, Taddeo, Skulsky, Wang, Jansen, Real-Time HPV PCR Assays. November 2, 2006), and WO 2006\/116303 A2 (Merck, Taddeo, Skulsky, Wang, Jansen, Fluorescent Multiplex HPV PCR Assays. November 2, 2006)"},{"issue":"1","key":"key\n\t\t\t\t20170520221005_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.AOG.0000192397.41191.fb","article-title":"Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial","volume":"107","author":"Mao","year":"2006","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20170520221005_bib28","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1080\/03610929808832160","article-title":"Exact power and sample size for vaccine efficacy studies","volume":"27","author":"Chan","year":"1998","journal-title":"Commun Stat Theory Methods"},{"key":"key\n\t\t\t\t20170520221005_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc."},{"issue":"10","key":"key\n\t\t\t\t20170520221005_bib30","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/1940-6207.CAPR-09-0031","article-title":"A pooled analysis of continued prophylactic efficacy of quadrivalent HPV (types 6\/11\/16\/18) vaccine against high-grade cervical and external genital lesions","volume":"2","author":"Kjaer","year":"2009","journal-title":"Cancer Prev Res."},{"issue":"1","key":"key\n\t\t\t\t20170520221005_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/00016340802566770","article-title":"The efficacy of HPV 16\/18 vaccines on sexually active 18\u201323 year old women and the impact of HPV vaccination on organized cervical cancer screening","volume":"88","author":"Sigurdsson","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key\n\t\t\t\t20170520221005_bib32","doi-asserted-by":"crossref","first-page":"S3\/S26","DOI":"10.1016\/j.vaccine.2006.05.026","article-title":"Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases","volume":"24","author":"Clifford","year":"2006","journal-title":"Vaccine"},{"issue":"12","key":"key\n\t\t\t\t20170520221005_bib33","first-page":"2335","article-title":"Management of genital warts","volume":"70","author":"Kodner","year":"2004","journal-title":"Am Fam Physician"},{"key":"key\n\t\t\t\t20170520221005_bib34","first-page":"600","article-title":"Warts, genital","volume-title":"Mimes Disease Index","author":"Garland","year":"1996","edition":"2nd ed"},{"key":"key\n\t\t\t\t20170520221005_bib35","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1016\/j.vaccine.2007.03.049","article-title":"Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6\/11\/16\/18 L1 virus-like-particle vaccine","volume":"25","author":"Olsson","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"key\n\t\t\t\t20170520221005_bib36","doi-asserted-by":"crossref","DOI":"10.4161\/hv.5.10.9515","article-title":"Evaluation of quadrivalent HPV 6\/11\/16\/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection [published online ahead of print]","volume":"5","author":"Olsson","year":"2009","journal-title":"Human Vaccines"},{"issue":"6","key":"key\n\t\t\t\t20170520221005_bib37","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine","volume":"199","author":"Garland","year":"2009","journal-title":"J Infect Dis"},{"issue":"8","key":"key\n\t\t\t\t20170520221005_bib38","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/ijc.23712","article-title":"Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of HPV-vaccination program in Denmark","volume":"123","author":"Kjaer","year":"2008","journal-title":"Int J Cancer"},{"issue":"6","key":"key\n\t\t\t\t20170520221005_bib39","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00001648-200211000-00006","article-title":"The theoretical population-level impact of a prophylactic human papilloma virus vaccine","volume":"13","author":"Hughes","year":"2002","journal-title":"Epidemiology"},{"issue":"5","key":"key\n\t\t\t\t20170520221005_bib40","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1128\/JVI.69.5.3074-3083.1995","article-title":"Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy","volume":"69","author":"Chan","year":"1995","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170520221005_bib41","volume-title":"Why it's Important to Monitor Vaccine Safety","author":"Centers for Disease Control and Prevention"},{"issue":"2","key":"key\n\t\t\t\t20170520221005_bib42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2249.2007.03384.x","article-title":"Translational mini-review series on vaccines: monitoring of human papillomavirus vaccination","volume":"148","author":"Dillner","year":"2007","journal-title":"Clin Exp Immunol"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/102\/5\/325\/17310863\/djp534.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T18:26:12Z","timestamp":1590603972000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djp534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,3]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2010,3,3]]},"published-print":{"date-parts":[[2010,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djp534","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3,3]]}}}